Vanguard Personalized Indexing Management’s ProQR Therapeutics PRQR Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio PRQR Stock Details PRQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$31.4K	Sell	19,410 -2,904	-13%	-$4.76K	﹤0.01%	2093
2025 Q4	$45.1K	Hold	22,314	–	–	﹤0.01%	1893
2025 Q3	$47.5K	Hold	22,314	–	–	﹤0.01%	1905
2025 Q2	$45.5K	Buy	22,314 +1,518	+7%	+$2.47K	﹤0.01%	1839
2025 Q1	$27.7K	Sell	20,796 -633	-3%	-$1.35K	﹤0.01%	1737
2024 Q4	$56.8K	Hold	21,429	–	–	﹤0.01%	1681
2024 Q3	$39K	Hold	21,429	–	–	﹤0.01%	1699
2024 Q2	$35.6K	Hold	21,429	–	–	﹤0.01%	1610
2024 Q1	$49.1K	Hold	21,429	–	–	﹤0.01%	1566
2023 Q4	$42.4K	Hold	21,429	–	–	﹤0.01%	1522
2023 Q3	$27.9K	Hold	21,429	–	–	﹤0.01%	1437
2023 Q2	$34.7K	Hold	21,429	–	–	﹤0.01%	1439
2023 Q1	$45.6K	Hold	21,429	–	–	﹤0.01%	1427
2022 Q4	$79.3K	Buy	+21,429	New	+$28.1K	﹤0.01%	1236
2022 Q3	–	Sell	-16,660	Closed	-$13K	–	1288
2022 Q2	$13K	Buy	16,660 +5,348	+47%	+$3.99K	﹤0.01%	1244
2022 Q1	$10K	Buy	+11,312	New	+$37.9K	﹤0.01%	1206

Other funds holding PRQR

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PFM

Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Vanguard Personalized Indexing Management's PRQR Position: Q1 2026 in Review

Vanguard Personalized Indexing Management reduced its ProQR Therapeutics (PRQR) stake by 13% in Q1 2026, selling an estimated $4.76K and leaving 19,410 shares worth $31.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2093.

Vanguard Personalized Indexing Management first reported a position in PRQR in Q1 2022 and has held it in 16 quarters since. The position peaked at $79.3K in Q4 2022. 69 funds tracked by Wall St. Rank hold PRQR as of Q1 2026.

Vanguard Personalized Indexing Management held 19,410 shares of ProQR Therapeutics worth $31.4K as of Q1 2026.
Vanguard Personalized Indexing Management sold 2,904 ProQR Therapeutics shares in Q1 2026, an estimated $4.76K.
ProQR Therapeutics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #2093 holding.
Vanguard Personalized Indexing Management first reported a position in ProQR Therapeutics in Q1 2022 and has held it in 16 quarters since.
Vanguard Personalized Indexing Management's ProQR Therapeutics position peaked at $79.3K in Q4 2022.
69 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.